1
|
Nakanuma Y, Curabo MP, Franceschi S, Gores
G, Paradis V, Sripa B, Tsui WMS and Wee A: Intrahepatic
cholangiocarcinoma. In: WHO Classification of Tumours of the
Digestive System. Bosman FT, Carneiro F, Hruban RH and Theise ND
(eds). 4th edition. IARC Press, Lyon, pp217-p224, 2010.
|
2
|
Albores-Saavedra J, Adsay NV, Crawford JM,
Klimstra DS, Klöppel G, Sripa B, Tsui WMS and Paradis V: Carcinoma
of the gallbladder and extrahepatic bile ducts. WHO Classification
of Tumours of the Digestive System: World Health Organization of
Tumours. Bosman FT, Carneiro F, Hruban RH and Theise ND (eds). 4th
edition. IARC Press, Lyon, pp266-p273, 2010.
|
3
|
Adsay V, Jang KT, Roa JC, Dursun N, Ohike
N, Bagci P, Basturk O, Bandyopadhyay S, Cheng JD, Sarmiento JM, et
al: Intracholecystic papillary-tubular neoplasms (ICPN) of the
gallbladder (neoplastic polyps, adenomas, and papillary neoplasms
that are ≥1.0 cm): Clinicopathologic and immunohistochemical
analysis of 123 cases. Am J Surg Pathol. 36:1279–1301.
2012.PubMed/NCBI View Article : Google Scholar
|
4
|
Menetrier P: Des polyadenomes gastriques
et deleurs rapports avec le cancer de l'estomac. Arch Physiol Norm
Pathol. 1:32–55, 236-262. 1888.
|
5
|
Jarnum S and Jensen KB: Plasma protein
turnover (albumin, transferrin, IgG, IgM) in Ménétrier's disease
(giant hypertrophic gastritis): Evidence of non-selective protein
loss. Gut. 13:128–137. 1972.PubMed/NCBI View Article : Google Scholar
|
6
|
Wolfsen HC, Carpenter HA and Talley NJ:
Menetrier's disease: A form of hypertrophic gastropathy or
gastritis? Gastroenterology. 104:1310–1319. 1993.PubMed/NCBI View Article : Google Scholar
|
7
|
Almazar AE, Penfield JD, Saito YA and
Talley NJ: Survival times of patients with Menetrier's disease and
risk of gastric cancer. Clin Gastroenterol Hepatol. 19:707–712.
2021.PubMed/NCBI View Article : Google Scholar
|
8
|
Kamal MU, Tariq H, Mehak V, Azam S, Kumar
K, Niazi M and Dev A: A rare etiology of abnormally large gastric
folds: Menetrier's disease. Case Rep Gastrointest Med.
2019(7927083)2019.PubMed/NCBI View Article : Google Scholar
|
9
|
Pryczynicz A, Bandurski R,
Guzińska-Ustymowicz K, Niewiarowska K, Kemona A and Kędra B:
Ménétrier's disease, a premalignant condition, with coexisting
advanced gastric cancer: A case report and review of the
literature. Oncol Lett. 8:441–445. 2014.PubMed/NCBI View Article : Google Scholar
|
10
|
Kuo AH, Martinez N and Rosenkranz L: A
concurrent case of Menetrier's disease and signet ring carcinoma.
ACG Case Rep J. 3(e176)2016.PubMed/NCBI View Article : Google Scholar
|
11
|
Zen Y, Sasaki M, Fujii T, Chen TC, Chen
MF, Yeh TS, Jan YY, Huang SF, Nimura Y and Nakanuma Y: Different
expression patterns of mucin core proteins and cytokeratins during
intrahepatic cholangiocarcinogenesis from biliary intraepithelial
neoplasia and intraductal papillary neoplasm of the bile duct - an
immunohistochemical study of 110 cases of hepatolithiasis. J
Hepatol. 44:350–358. 2006.PubMed/NCBI View Article : Google Scholar
|
12
|
Rocha FG, Lee H, Katabi N, DeMatteo RP,
Fong Y, D'Angelica MI, Allen PJ, Klimstra DS and Jarnagin WR:
Intraductal papillary neoplasm of the bile duct: A biliary
equivalent to intraductal papillary mucinous neoplasm of the
pancreas? Hepatology. 56:1352–1360. 2012.PubMed/NCBI View Article : Google Scholar
|
13
|
Argon A, Barbet FY and Nart D: The
relationship between intracholecystic papillary-tubular neoplasms
and invasive carcinoma of the gallbladder. Int J Surg Pathol.
24:504–511. 2016.PubMed/NCBI View Article : Google Scholar
|
14
|
Hara A, Kamata K, Takenaka M, Chikugo T
and Kudo M: Intracystic papillary neoplasm preoperatively diagnosed
by high-quality cytology derived from endoscopic nasogallbladder
drainage. Gastrointest Endosc. 89:1257–1259. 2019.PubMed/NCBI View Article : Google Scholar
|
15
|
Akita M, Fujikura K, Ajiki T, Fukumoto T,
Otani K, Hirose T, Tominaga M, Itoh T and Zen Y: Intracholecystic
papillary neoplasms are distinct from papillary gallbladder
cancers: A clinicopathologic and exome-sequencing study. Am J Surg
Pathol. 43:783–791. 2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Kang JS, Lee KB, Choi YJ, Byun Y, Han Y,
Kim H, Kwon W and Jang JY: A comparison of outcomes in patients
with intracholecystic papillary neoplasms or conventional
adenocarcinomas of the gallbladder. Available from: https://doi.org/10.1016/j.hpb.2020.09.011.
|
17
|
Creasy JM, Goldman DA, Gonen M, Dudeja V,
O'Reilly EM, Abou-Alfa GK, Cercek A, Harding JJ, Balachandran VP,
Drebin JA, et al: Evolution of surgical management of gallbladder
carcinoma and impact on outcome: Results from two decades at a
single-institution. HPB (Oxford). 21:1541–1551. 2019.PubMed/NCBI View Article : Google Scholar
|
18
|
Dempsey PJ, Goldenring JR, Soroka CJ,
Modlin IM, McClure RW, Lind CD, Ahlquist DA, Pittelkow MR, Lee DC,
Sandgren EP, et al: Possible role of transforming growth factor
alpha in the pathogenesis of Ménétrier's disease: Supportive
evidence form humans and transgenic mice. Gastroenterology.
103:1950–1963. 1992.PubMed/NCBI View Article : Google Scholar
|
19
|
Nomura S, Settle SH, Leys CM, Means AL,
Peek RM Jr, Leach SD, Wright CV, Coffey RJ and Goldenring JR:
Evidence for repatterning of the gastric fundic epithelium
associated with Ménétrier's disease and TGFalpha overexpression.
Gastroenterology. 128:1292–1305. 2005.PubMed/NCBI View Article : Google Scholar
|
20
|
Kidd M, Schimmack S, Lawrence B, Alaimo D
and Modlin IM: EGFR/TGFalpha and TGFbeta/CTGF signaling in
neuroendocrine neoplasia: Theoretical therapeutic targets.
Neuroendocrinology. 97:35–44. 2013.PubMed/NCBI View Article : Google Scholar
|
21
|
Ciardiello F and Tortora G: Epidermal
growth factor receptor (EGFR) as a target in cancer therapy:
Understanding the role of receptor expression and other molecular
determinants that could influence the response to anti-EGFR drugs.
Eur J Cancer. 39:1348–1354. 2003.PubMed/NCBI View Article : Google Scholar
|
22
|
Badov D, Lambert JR, Finlay M and Balazs
ND: Helicobacter pylori as a pathogenic factor in
Ménétrier's disease. Am J Gastroenterol. 93:1976–1979.
1998.PubMed/NCBI View Article : Google Scholar
|
23
|
Megged O and Schlesinger Y:
Cytomegalovirus-associated protein-losing gastropathy in childhood.
Eur J Pediatr. 167:1217–1220. 2008.PubMed/NCBI View Article : Google Scholar
|
24
|
Sato N, Nakahara K, Morita R, Suetani K,
Michikawa Y, Nakano H, Koizumi S, Otsubo T, Fujino T and Itoh F: A
case of Ménétrier's disease seemingly caused by hilar
cholangiocarcinoma. Nihon Shokakibyo Gakkai Zasshi. 113:975–982.
2016.PubMed/NCBI View Article : Google Scholar
|
25
|
Takemura K, Obara T, Okano S, Yokota K,
Ura H, Saitoh Y, Koike Y, Okamura K and Namiki M:
Immunohistochemical study on the expression of epidermal growth
factor receptor (EGFR) in human colorectal carcinomas. Nihon
Shokakibyo Gakkai Zasshi. 88:1177–1183. 1991.PubMed/NCBI
|
26
|
Schaad U, Zimmermann A, Gaze H, Kaiser G,
Vésy J and Hadorn B: Protein-losing enteropathy due to segmental
erosive and ulcerative intestinal disease cured by limited
resection of the bowel. Helv Paediatr Acta. 33:289–297.
1978.PubMed/NCBI
|
27
|
Lenzhofer R, Lindner M, Moser A, Berger J,
Schuschnigg C and Thurner J: Acute jejunal ileus in intestinal
lymphangiectasia. Clin Investig. 71:568–571. 1993.PubMed/NCBI View Article : Google Scholar
|
28
|
Shima T, Ozeki M, Kinoshita T, Honda K,
Inoue H and Morita S: Protein-losing enteropathy secondary to
nonocclusive mesenteric ischemia: A case report. Medicine
(Baltimore). 97(e13403)2018.PubMed/NCBI View Article : Google Scholar
|